|Day Low/High||0.76 / 0.80|
|52 Wk Low/High||0.75 / 10.90|
Release profile of Midatech's Q-Octreotide compared favourably with the reference product and current market leader
Programme is delivering on track for an IND in H2 2017
Midatech further expands its commercial footprint in US, supporting the Zuplenz® launch
Dosing Has Commenced With MTX110 for DIPG on a Named Patient Basis
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.